Login to Your Account

IDM Seeking EUR92 Million In IPO To Fund Programs In Cancer

By James Etheridge

Wednesday, June 9, 2004
PARIS - Immuno-Designed Molecules SA proposed an IPO on the Nouveau Marche of the Euronext stock exchange in Paris last week, offering 8.1 million shares at €10.50 to €12.20 per share. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription